Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Managing Gout in the Patient with Renal Impairment.

Pascual E, Sivera F, Andrés M.

Drugs Aging. 2018 Feb 13. doi: 10.1007/s40266-018-0517-7. [Epub ahead of print]

PMID:
29435850
2.

Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice.

Perez Ruiz F, Sanchez-Piedra CA, Sanchez-Costa JT, Andrés M, Diaz-Torne C, Jimenez-Palop M, De Miguel E, Moragues C, Sivera F.

Rheumatol Ther. 2017 Dec 4. doi: 10.1007/s40744-017-0091-1. [Epub ahead of print]

3.

Validation of a Definition of Flare in Patients With Established Gout.

Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS, Chen YH, Lin CT, Bourke S, Louthrenoo W, Vazquez-Mellado J, Hernández-Llinas H, Neogi T, Vargas-Santos AB, da Rocha Castelar-Pinheiro G, Amorim RBC, Uhlig T, Hammer HB, Eliseev M, Perez-Ruiz F, Cavagna L, McCarthy GM, Stamp LK, Gerritsen M, Fana V, Sivera F, Taylor W.

Arthritis Rheumatol. 2017 Nov 21. doi: 10.1002/art.40381. [Epub ahead of print]

PMID:
29161469
4.

Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology.

Seoane-Mato D, Sánchez-Piedra C, Silva-Fernández L, Sivera F, Blanco FJ, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis Martí N, Cortés Verdú R, Antón-Pagés F, Quevedo Vila V, Garrido Courel L, Del Amo NDV, Paniagua Zudaire I, Añez Sturchio G, Medina Varo F, Ruiz Tudela MDM, Romero Pérez A, Ballina J, Brandy García A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, González Álvarez B, Casas Hernández L, Álvarez Reyes F, Delgado Sánchez M, Martínez Dubois C, Sánchez-Fernández SÁ, Rojas Vargas LM, García Morales PV, Olivé A, Rubio Muñoz P, Larrosa M, Navarro Ricos N, Graell Martín E, Chamizo E, Chaves Chaparro L, Rojas Herrera S, Pons Dolset J, Polo Ostariz MÁ, Ruiz-Alejos Garrido S, Macía Villa C, Cruz Valenciano A, González Gómez ML, Morcillo Valle M, Palma Sánchez D, Moreno Martínez MJ, Mayor González M, Atxotegi Sáenz de Buruaga J, Urionagüena Onaindia I, Blanco Cáceres BA, Díaz-González F, Bustabad S.

Reumatol Clin. 2017 Jul 31. pii: S1699-258X(17)30168-7. doi: 10.1016/j.reuma.2017.06.009. [Epub ahead of print] English, Spanish.

5.

Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment.

Andrés M, Bernal JA, Sivera F, Quilis N, Carmona L, Vela P, Pascual E.

Ann Rheum Dis. 2017 Jul;76(7):1263-1268. doi: 10.1136/annrheumdis-2016-210357. Epub 2017 Jan 16.

PMID:
28093417
6.

Erratum to: Rheumatology training experience across Europe: analysis of core competences.

Sivera F, Ramiro S, Cikes N, Cutolo M, Dougados M, Gossec L, Kvien TK, Lundberg IE, Mandl P, Moorthy A, Panchal S, da Silva JA, Bijlsma JW; Working Group on Training in Rheumatology across Europe.

Arthritis Res Ther. 2016 Dec 19;18(1):300. No abstract available.

7.

Gout: Diagnosis and treatment.

Sivera F, Andrés M, Quilis N.

Med Clin (Barc). 2017 Mar 22;148(6):271-276. doi: 10.1016/j.medcli.2016.10.019. Epub 2016 Dec 5. English, Spanish. No abstract available.

PMID:
27931865
8.

Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard.

Dalbeth N, Schumacher HR, Fransen J, Neogi T, Jansen TL, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Cimmino MA, Uhlig T, Taylor WJ.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1894-1898. doi: 10.1002/acr.22896. Epub 2016 Oct 28.

9.

Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard.

Ogdie A, Taylor WJ, Neogi T, Fransen J, Jansen TL, Schumacher HR, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Cagnotto G, Cavagna L, Lin C, Chou YY, Tausche AK, Lima Gomes Ochtrop M, Janssen M, Chen JH, Slot O, Lazovskis J, White D, Cimmino MA, Uhlig T, Dalbeth N.

Arthritis Rheumatol. 2017 Feb;69(2):429-438. doi: 10.1002/art.39959.

10.

Rheumatology training experience across Europe: analysis of core competences.

Sivera F, Ramiro S, Cikes N, Cutolo M, Dougados M, Gossec L, Kvien TK, Lundberg IE, Mandl P, Moorthy A, Panchal S, da Silva JA, Bijlsma JW; Working Group on Training in Rheumatology across Europe.

Arthritis Res Ther. 2016 Sep 23;18(1):213. Erratum in: Arthritis Res Ther. 2016 Dec 19;18(1):300.

11.

Centre characteristics determine ambulatory care and referrals in patients with spondyloarthritis.

Andrés M, Sivera F, Pérez-Vicente S, Vela P, Carmona L; EMAR II study group.

Rheumatol Int. 2016 Nov;36(11):1515-1523. Epub 2016 Aug 6.

PMID:
27498017
12.

Educational needs and preferences of young European clinicians and physician researchers working in the field of rheumatology.

Beyer C, Ramiro S, Sivera F, Mandl P, Machado PM, Ospelt C, Moltó A, Radner H, Iagnocco A, Bijlsma JW, Lundberg IE; EMEUNET country liaisons group .

RMD Open. 2016 Jul 27;2(2):e000240. doi: 10.1136/rmdopen-2015-000240. eCollection 2016.

13.

Centre-related variability in hospital admissions of patients with spondyloarthritis.

Andrés M, Sivera F, Pérez-Vicente S, Carmona L, Vela P; EMAR II study group.

Rheumatol Int. 2016 Sep;36(9):1301-8. doi: 10.1007/s00296-016-3519-y. Epub 2016 Jul 2.

PMID:
27372079
14.

Gout mimicking rheumatoid arthritis.

Sivera F, Andres M, Pascual E.

Semin Arthritis Rheum. 2016 Jun;45(6):e28. doi: 10.1016/j.semarthrit.2016.03.007. Epub 2016 Mar 16. No abstract available.

PMID:
27105757
15.

Gout: optimizing treatment to achieve a disease cure.

Bernal JA, Quilis N, Andrés M, Sivera F, Pascual E.

Ther Adv Chronic Dis. 2016 Mar;7(2):135-44. doi: 10.1177/2040622315618393. Epub 2016 Jan 12. Review.

16.

Current advances in therapies for calcium pyrophosphate crystal arthritis.

Sivera F, Andrés M, Pascual E.

Curr Opin Rheumatol. 2016 Mar;28(2):140-4. doi: 10.1097/BOR.0000000000000252. Review.

PMID:
26780424
17.

Silent Monosodium Urate Crystal Deposits Are Associated With Severe Coronary Calcification in Asymptomatic Hyperuricemia: An Exploratory Study.

Andrés M, Quintanilla MA, Sivera F, Sánchez-Payá J, Pascual E, Vela P, Ruiz-Nodar JM.

Arthritis Rheumatol. 2016 Jun;68(6):1531-9. doi: 10.1002/art.39581.

18.

Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Ralph Schumacher H, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

J Rheumatol. 2016 Jan;43(1):150-3. doi: 10.3899/jrheum.150684. Epub 2015 Dec 1.

PMID:
26628602
19.

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.

de Lautour H, Taylor WJ, Adebajo A, Alten R, Burgos-Vargas R, Chapman P, Cimmino MA, da Rocha Castelar Pinheiro G, Day R, Harrold LR, Helliwell P, Janssen M, Kerr G, Kavanaugh A, Khanna D, Khanna PP, Lin C, Louthrenoo W, McCarthy G, Vazquez-Mellado J, Mikuls TR, Neogi T, Ogdie A, Perez-Ruiz F, Schlesinger N, Ralph Schumacher H, Scirè CA, Singh JA, Sivera F, Slot O, Stamp LK, Tausche AK, Terkeltaub R, Uhlig T, van de Laar M, White D, Yamanaka H, Zeng X, Dalbeth N.

Arthritis Care Res (Hoboken). 2016 May;68(5):667-72. doi: 10.1002/acr.22741.

20.

Mechanisms of crystal formation in gout-a structural approach.

Pascual E, Addadi L, Andrés M, Sivera F.

Nat Rev Rheumatol. 2015 Dec;11(12):725-30. doi: 10.1038/nrrheum.2015.125. Epub 2015 Sep 15. Review.

PMID:
26369610
21.

Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: Ascertaining the Efficacy of Treatment Matters.

Andrés M, Sivera F, Pascual E.

Am J Med. 2015 Sep;128(9):e41-2. doi: 10.1016/j.amjmed.2015.03.029. No abstract available.

PMID:
26319669
22.

Response to 'dual training in general internal medicine and rheumatology: the Irish context' by Dr Sheane.

Sivera F, Ramiro S, Bijlsma JW.

Ann Rheum Dis. 2015 Sep;74(9):e56. doi: 10.1136/annrheumdis-2015-207813. Epub 2015 May 29. No abstract available.

PMID:
26025970
23.

Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?

Pascual E, Andrés M, Sivera F.

Arthritis Res Ther. 2015 Apr 1;17:89. doi: 10.1186/s13075-015-0598-1.

24.

Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout.

Taylor WJ, Fransen J, Jansen TL, Dalbeth N, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, Vargas-Santos AB, Janssen M, Chen JH, Slot O, Cimmino MA, Uhlig T, Neogi T.

Arthritis Care Res (Hoboken). 2015 Sep;67(9):1304-15. doi: 10.1002/acr.22585.

25.

Differences and similarities in rheumatology specialty training programmes across European countries.

Sivera F, Ramiro S, Cikes N, Dougados M, Gossec L, Kvien TK, Lundberg IE, Mandl P, Moorthy A, Panchal S, da Silva JA, Bijlsma JW; Working Group on Training in Rheumatology across Europe.

Ann Rheum Dis. 2015 Jun;74(6):1183-7. doi: 10.1136/annrheumdis-2014-206791. Epub 2015 Mar 6. Erratum in: Ann Rheum Dis. 2017 Jan;76(1):314.

PMID:
25749050
26.

Performance of classification criteria for gout in early and established disease.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

Ann Rheum Dis. 2016 Jan;75(1):178-82. doi: 10.1136/annrheumdis-2014-206364. Epub 2014 Oct 28.

PMID:
25351521
27.

Dietary supplements for chronic gout.

Andrés M, Sivera F, Falzon L, Buchbinder R, Carmona L.

Cochrane Database Syst Rev. 2014 Oct 7;(10):CD010156. doi: 10.1002/14651858.CD010156.pub2. Review.

PMID:
25287939
28.

MRI myositis sine myositis: the importance of the histopathology.

Andrés M, Sivera F, Alonso S, Pack C.

Rheumatology (Oxford). 2015 Jan;54(1):76. doi: 10.1093/rheumatology/keu370. Epub 2014 Sep 18. No abstract available.

PMID:
25239879
29.

Treatment target and followup measures for patients with gout: a systematic literature review.

Andrés M, Sivera F, Falzon L, van der Heijde DM, Carmona L.

J Rheumatol Suppl. 2014 Sep;92:55-62. doi: 10.3899/jrheum.140463. Review.

PMID:
25180129
30.

The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors.

Wechalekar MD, Vinik O, Moi JH, Sivera F, van Echteld IA, van Durme C, Falzon L, Bombardier C, Carmona L, Aletaha D, Landewé RB, van der Heijde DM, Buchbinder R.

J Rheumatol Suppl. 2014 Sep;92:15-25. doi: 10.3899/jrheum.140458. Review.

PMID:
25180124
31.

Diagnostic value of clinical, laboratory, and imaging findings in patients with a clinical suspicion of gout: a systematic literature review.

Sivera F, Andrès M, Falzon L, van der Heijde DM, Carmona L.

J Rheumatol Suppl. 2014 Sep;92:3-8. doi: 10.3899/jrheum.140456. Review.

PMID:
25180122
32.

Interleukin-1 inhibitors for acute gout.

Sivera F, Wechalekar MD, Andrés M, Buchbinder R, Carmona L.

Cochrane Database Syst Rev. 2014 Sep 1;(9):CD009993. doi: 10.1002/14651858.CD009993.pub2. Review.

PMID:
25177840
33.

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.

Sivera F, Andrés M, Carmona L, Kydd AS, Moi J, Seth R, Sriranganathan M, van Durme C, van Echteld I, Vinik O, Wechalekar MD, Aletaha D, Bombardier C, Buchbinder R, Edwards CJ, Landewé RB, Bijlsma JW, Branco JC, Burgos-Vargas R, Catrina AI, Elewaut D, Ferrari AJ, Kiely P, Leeb BF, Montecucco C, Müller-Ladner U, Ostergaard M, Zochling J, Falzon L, van der Heijde DM.

Ann Rheum Dis. 2014 Feb;73(2):328-35. doi: 10.1136/annrheumdis-2013-203325. Epub 2013 Jul 18.

34.

A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria.

Prowse RL, Dalbeth N, Kavanaugh A, Adebajo AO, Gaffo AL, Terkeltaub R, Mandell BF, Suryana BP, Goldenstein-Schainberg C, Diaz-Torne C, Khanna D, Lioté F, Mccarthy G, Kerr GS, Yamanaka H, Janssens H, Baraf HF, Chen JH, Vazquez-Mellado J, Harrold LR, Stamp LK, Van De Laar MA, Janssen M, Doherty M, Boers M, Edwards NL, Gow P, Chapman P, Khanna P, Helliwell PS, Grainger R, Schumacher HR, Neogi T, Jansen TL, Louthrenoo W, Sivera F, Taylor WJ, Alten R.

J Rheumatol. 2013 Apr;40(4):498-505. doi: 10.3899/jrheum.121037. Epub 2013 Feb 15. Erratum in: J Rheumatol. 2013 Sep;40(9):1634. Alten, Rieke [added].

PMID:
23418379
35.

Methotrexate is an option for patients with refractory calcium pyrophosphate crystal arthritis.

Andres M, Sivera F, Pascual E.

J Clin Rheumatol. 2012 Aug;18(5):234-6. doi: 10.1097/RHU.0b013e3182611471.

PMID:
22832286
36.

Developing a provisional definition of flare in patients with established gout.

Gaffo AL, Schumacher HR, Saag KG, Taylor WJ, Dinnella J, Outman R, Chen L, Dalbeth N, Sivera F, Vázquez-Mellado J, Chou CT, Zeng X, Perez-Ruiz F, Kowalski SC, Goldenstein-Schainberg C, Chen L, Bardin T, Singh JA.

Arthritis Rheum. 2012 May;64(5):1508-17. doi: 10.1002/art.33483.

37.

Rheumatology education in Europe: results of a survey of young rheumatologists.

Bandinelli F, Bijlsma JW, Ramiro MS, Pia E, Goekoop-Ruiterman YP, Sivera F, Molto Revilla A, Marinescu C, Rimar D, Norkuviene E, Mayer M, Duarte Marques CC, da Silva JA, Cutolo M.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5):843-5. Epub 2011 Oct 31.

PMID:
22011355
38.

Synovial fluid analysis for crystals.

Pascual E, Sivera F, Andrés M.

Curr Opin Rheumatol. 2011 Mar;23(2):161-9. doi: 10.1097/BOR.0b013e328343e458. Review.

PMID:
21285711
39.

EULAR recommendations for calcium pyrophosphate deposition. Part II: management.

Zhang W, Doherty M, Pascual E, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhlig T, Watt I, Bardin T.

Ann Rheum Dis. 2011 Apr;70(4):571-5. doi: 10.1136/ard.2010.139360. Epub 2011 Jan 20.

PMID:
21257614
40.

European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.

Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhlig T, Watt I, Pascual E.

Ann Rheum Dis. 2011 Apr;70(4):563-70. doi: 10.1136/ard.2010.139105. Epub 2011 Jan 7.

PMID:
21216817
41.

Severe ischemia following treatment with rituximab in a patient with mixed connective tissue disease: an unusual complication.

Vela P, Sivera F, Batlle-Gualda E, Mayor M, García-Manzanares A, Pascual E.

Lupus. 2010 Jul;19(8):1005-6. doi: 10.1177/0961203310369145. No abstract available.

PMID:
20581023
42.

Progress in measurement instruments for acute and chronic gout studies.

Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, Schlesinger N, Evans R, Edwards NL, Sivera F, Diaz-Torne C, MacDonald PA, McQueen FM, Schumacher HR.

J Rheumatol. 2009 Oct;36(10):2346-55. doi: 10.3899/jrheum.090371.

PMID:
19820224
43.

Outcome domains for studies of acute and chronic gout.

Schumacher HR, Taylor W, Edwards L, Grainger R, Schlesinger N, Dalbeth N, Sivera F, Singh J, Evans R, Waltrip RW, Diaz-Torne C, MacDonald P, McQueen F, Perez-Ruiz F.

J Rheumatol. 2009 Oct;36(10):2342-5. doi: 10.3899/jrheum.090370.

PMID:
19820223
44.

Febuxostat.

Pascual E, Sivera F, Yasothan U, Kirkpatrick P.

Nat Rev Drug Discov. 2009 Mar;8(3):191-2. doi: 10.1038/nrd2831. No abstract available.

PMID:
19247302
45.

Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years.

Bennett AN, McGonagle D, O'Connor P, Hensor EM, Sivera F, Coates LC, Emery P, Marzo-Ortega H.

Arthritis Rheum. 2008 Nov;58(11):3413-8. doi: 10.1002/art.24024.

46.

MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib.

Jarrett SJ, Sivera F, Cawkwell LS, Marzo-Ortega H, McGonagle D, Hensor E, Coates L, O'Connor PJ, Fraser A, Conaghan PG, Emery P.

Ann Rheum Dis. 2009 Sep;68(9):1466-9. doi: 10.1136/ard.2008.092213. Epub 2008 Oct 24. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
18952641
47.

[Diagnosis of microcrystalline arthropathy].

Pascual E, Sivera F.

Reumatol Clin. 2008 Oct;4 Suppl 2:45-9. doi: 10.1016/S1699-258X(08)76168-0. Epub 2009 Apr 7. Spanish.

48.

Why is gout so poorly managed?

Pascual E, Sivera F.

Ann Rheum Dis. 2007 Oct;66(10):1269-70. Review. No abstract available.

49.

First metatarsophalangeal joint aspiration using a 29-gauge needle.

Sivera F, Aragon R, Pascual E.

Ann Rheum Dis. 2008 Feb;67(2):273-5. Epub 2007 Jun 8.

PMID:
17557892
50.

Therapeutic advances in gout.

Pascual E, Sivera F.

Curr Opin Rheumatol. 2007 Mar;19(2):122-7. Review.

PMID:
17278926

Supplemental Content

Loading ...
Support Center